Hemanth Kumar Manikyam: The Complex Immunology Behind Platelet Destruction in ITP
Hemanth Kumar Manikyam, Vice President of Research And Development at Botanic Healthcare, Visiting Professor at Chalapathi Institute of Pharmaceutical Sciences, Lam, shared a post on LinkedIn:
“Immune thrombocytopenia (ITP): A B-cell-macrophage immune network disorder?
Insights from Mother INP 11-Layer Analysis.
Immune Thrombocytopenia (ITP) is commonly described as a low platelet disorder.
However, our Mother INP 11-Layer analysis suggests that ITP is fundamentally an immune network disease involving autoantibody production, immune tolerance failure, chronic inflammation, excessive macrophage activity, and impaired platelet regeneration.
The primary failure nodes identified include:
- B-cell hyperactivation
- Autoantibody production against platelet glycoproteins
- Regulatory T-cell dysfunction
- Splenic macrophage overactivity
- NF-κB activation
- TNF-α and IL-6 elevation
- Megakaryocyte dysfunction
KEGG pathway prioritization highlighted B-cell receptor signaling, Fcγ receptor signaling, JAK-STAT, NF-κB, PI3K-AKT, complement activation, and cytokine-mediated immune pathways as key drivers of disease progression.
Using the Mother INP Engine, several phytochemicals emerged as high-priority restoration molecules.
Curcumin demonstrated broad immune-modulating effects through NF-κB, TNF-α, and IL-6 regulation.
Withanolides from Ashwagandha showed potential to support immune homeostasis and reduce inflammatory burden.
Quercetin demonstrated activity across cytokine signaling, oxidative stress reduction, and immune regulation pathways.
EGCG exhibited interactions with JAK-STAT and inflammatory signaling networks while supporting antioxidant defense systems.
The highest-priority recovery nodes identified were:
- Immune tolerance restoration
- Reduction of autoantibody formation
- Regulation of B-cell activity
- Suppression of excessive macrophage-mediated platelet destruction
- NF-κB modulation
- Cytokine balance restoration
- Support of megakaryocyte maturation
Network propagation analysis suggests that platelet destruction is not an isolated event but a downstream consequence of a larger immune signaling imbalance involving B cells, T cells, macrophages, cytokines, and inflammatory mediators.
The most promising phytochemical restoration cluster identified through the Mother INP framework was:
Epicatechin plus Curcumin plus Withanolides plus Quercetin plus EGCG working across multiple immune and inflammatory nodes simultaneously.
Mother INP Conclusion:
ITP is not simply a platelet deficiency disorder.
It is a systems-level immune dysregulation syndrome driven by immune tolerance failure, autoantibody production, inflammatory signaling, and hematological imbalance.”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”
-
Sep 4, 2026, 21:41Chokri Ben Lamine: Fundamental HSCT Workshop for Hematology Fellows at HAAG 2026
-
Sep 4, 2026, 21:39Pierre Sabouret: A Good Surprise Our New Publication in Life Is Online